# OnCo record oncternal-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oncternal-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oncternal-therapeutics" ;
  schema:name "Oncternal Therapeutics"@en ;
  schema:alternateName "Oncternal Therapeutics, Inc."@en, "GTx"@en, "NASDAQ:ONCT"@en ;
  schema:description "Oncternal Therapeutics is a San Diego biotech that developed the ROR1 antibody zilovertamab, licensed to Merck as an antibody-drug conjugate, and TK216, a small molecule against the EWS-FLI1 fusion that drives Ewing sarcoma."@en ;
  schema:url <https://onco.cc/companies/oncternal-therapeutics/>, <https://www.oncternal.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.oncternal.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/tk216/> .